1-4 of 4
Bailin He
Close
Sort by
Journal Articles

CD19-Specific CAR NK Cells Coexpressing IL-21 Exhibit Superior Expansion and Antitumor Activity Against CD19-Postive Lymphoma

Bailin He, Hong Chen, Shikai Deng, Chengyao Li, Na Xu, Xiaoli Liu, Hongsheng Zhou, Qifa Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6824.
https://doi.org/10.1182/blood-2023-178289
Published: 2023
Journal Articles

Disruption of SOCS1 Promotes the Antitumor Activity of CD19-Specific CAR NK Cells Coexpressing IL-15

Hong Chen, Bailin He, Suzhen Zhong, Dongchao Huang, Shikai Deng, Qifa Liu, Chengyao Li, Lizhen Huang, Na Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6829.
https://doi.org/10.1182/blood-2023-182516
Published: 2023
Journal Articles

Efficacy and Safety of TLR2 Co-Stimulated CAR T Cells in CD19-Positive Lymphoid Malignancies with Central Nervous System Involvement

Bailin He, Hongsheng Zhou, Ren Lin, Zhixiang Wang, Na Xu, Qiang Wang, Jing Sun, Xiaoli Liu, Peng Li, Qifa Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3484.
https://doi.org/10.1182/blood-2023-184492
Published: 2023
Journal Articles

Blockade of CD95/CD95L Death Signaling Enhances CAR T Cell Persistence and Antitumor Efficacy

Bailin He, PhD, Lei Wang, MD, Brigitte Neuber, Anita Schmitt, MD, Niclas Kneisel, PhD, Thomas Hoeger, PhD, Carsten Mueller-Tidow, MD, Michael Schmitt, MD, Susanne Hofmann, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3226.
https://doi.org/10.1182/blood-2019-122833
Published: 2019